Prostate cancer (PCa) is the second most common cancer in men and has a significant health and social burden, necessitating advances in early detection, prognosis, and treatment strategies. Improvement in medical imaging has significantly impacted early PCa detection, characterization, and treatment planning. However, with an increasing number of patients with PCa and comparatively fewer PCa imaging experts, interpreting large numbers of imaging data is burdensome, time-consuming, and prone to variability among experts. With the revolutionary advances of artificial intelligence (AI) in medical imaging, image interpretation tasks are becoming easier and exhibit the potential to reduce the workload on physicians. Generative AI (GenAI) is a recently popular sub-domain of AI that creates new data instances, often to resemble patterns and characteristics of the real data. This new field of AI has shown significant potential for generating synthetic medical images with diverse and clinically relevant information. In this narrative review, we discuss the basic concepts of GenAI and cover the recent application of GenAI in the PCa imaging domain. This review will help the readers understand where the PCa research community stands in terms of various medical image applications like generating multi-modal synthetic images, image quality improvement, PCa detection, classification, and digital pathology image generation. We also address the current safety concerns, limitations, and challenges of GenAI for technical and clinical adaptation, as well as the limitations of current literature, potential solutions, and future directions with GenAI for the PCa community.

Accurate stratification of the activity index of Crohn's disease (CD) using computed tomography enterography (CTE) radiomics and serum markers can aid in predicting disease progression and assist physicians in personalizing therapeutic regimens for patients with CD. This retrospective study enrolled 233 patients diagnosed with CD between January 2019 and August 2024. Patients were divided into training and testing cohorts at a ratio of 7:3 and further categorized into remission, mild active phase, and moderate-severe active phase groups based on simple endoscopic score for CD (SEC-CD). Radiomics features were extracted from CTE venous images, and T-test and least absolute shrinkage and selection operator (LASSO) regression were applied for feature selection. The serum markers were selected based on the variance analysis. We also developed a random forest (RF) model for multi-class stratification of CD. The model performance was evaluated by the area under the receiver operating characteristic curve (AUC) and quantified the contribution of each feature in the dataset to CD activity via Shapley additive exPlanations (SHAP) values. Finally, we enrolled gender, radiomics scores, and serum scores to develop a nomogram model to verify the effectiveness of feature extraction. 14 non-zero coefficient radiomics features and six serum markers with significant differences (P<0.01) were ultimately selected to predict CD activity. The AUC (micro/macro) for the ensemble machine learning model combining the radiomics features and serum markers is 0.931/0.928 for three-class. The AUC for the remission phase, the mild active phase, and the moderate-severe active phase were 0.983, 0.852, and 0.917, respectively. The mean AUC for the nomogram model was 0.940. A radiomics model was developed by integrating radiomics and serum markers of CD patients, achieving enhanced consistency with SEC-CD in grade CD. This model has the potential to assist clinicians in accurate diagnosis and treatment.

As technological innovation in computers has advanced, radiologists may now diagnose brain tumors (BT) with the use of artificial intelligence (AI). In the medical field, early disease identification enables further therapies, where the use of AI systems is essential for time and money savings. The difficulties presented by various forms of Magnetic Resonance (MR) imaging for BT detection are frequently not addressed by conventional techniques. To get around frequent problems with traditional tumor detection approaches, deep learning techniques have been expanded. Thus, for BT segmentation utilizing MR images, a U-Net-based architecture combined with Attention Mechanisms has been developed in this work. Moreover, by fine-tuning essential variables, Hyperparameter Optimization (HPO) is used using the Bayesian Optimization Algorithm to strengthen the segmentation model's performance. Tumor regions are pinpointed for segmentation using Region-Adaptive Thresholding technique, and the segmentation results are validated against ground truth annotated images to assess the performance of the suggested model. Experiments are conducted using the LGG, Healthcare, and BraTS 2021 MRI brain tumor datasets. Lastly, the importance of the suggested model has been demonstrated through comparing several metrics, such as IoU, accuracy, and DICE Score, with current state-of-the-art methods. The U-Net-based method gained a higher DICE score of 0.89687 in the segmentation of MRI-BT.

This research aimed to compare the classification accuracy of three machine learning (ML) methods (random forest (RF), support vector machines (SVM), linear discriminant analysis (LDA)) for sex estimation of sub-adults using cranial computed tomography (CCT) images. A total of 521 CCT scans from sub-adult Malaysians aged 0 to 20 were analysed using Mimics software (Materialise Mimics Ver. 21). Plane-to-plane (PTP) protocol was used for measuring 14 chosen craniometric parameters. A trio of machine learning algorithms RF, SVM, and LDA with GridSearchCV was used to produce classification models for sex estimation. In addition, performance was measured in the form of accuracy, precision, recall, and F1-score, among others. RF produced testing accuracy of 73%, with the best hyperparameters of max_depth = 6, max_samples = 40, and n_estimators = 45. SVM obtained an accuracy of 67% with the best hyperparameters: learning rate (C) = 10, gamma = 0.01, and kernel = radial basis function (RBF). LDA obtained the lowest accuracy of 65% with shrinkage of 0.02. Among the tested ML methods, RF showed the highest testing accuracy in comparison to SVM and LDA. This is the first AI-based classification model that can be used for estimating sex in sub-adults using CCT scans.

Precise delineation of brain tissues, including lesions, in MR images is crucial for data analysis and objectively assessing conditions like neurological disorders and brain tumors. Existing methods for tissue segmentation often fall short in addressing patients with lesions, particularly those with brain tumors. This study aimed to develop and evaluate a robust pipeline utilizing convolutional neural networks for rapid and automatic segmentation of whole brain tissues, including tumor lesions. The proposed pipeline was developed using BraTS'21 data (1251 patients) and tested on local hospital data (100 patients). Ground truth masks for lesions as well as brain tissues were generated. Two convolutional neural networks based on deep residual U-Net framework were trained for segmenting brain tissues and tumor lesions. The performance of the pipeline was evaluated on independent test data using dice similarity coefficient (DSC) and volume similarity (VS). The proposed pipeline achieved a mean DSC of 0.84 and a mean VS of 0.93 on the BraTS'21 test data set. On the local hospital test data set, it attained a mean DSC of 0.78 and a mean VS of 0.91. The proposed pipeline also generated satisfactory masks in cases where the SPM12 software performed inadequately. The proposed pipeline offers a reliable and automatic solution for segmenting brain tissues and tumor lesions in MR images. Its adaptability makes it a valuable tool for both research and clinical applications, potentially streamlining workflows and enhancing the precision of analyses in neurological and oncological studies.

&#xD;Radiotherapy (RT) has become increasingly sophisticated, necessitating advanced tools for analyzing extensive treatment data in hospital databases. Such analyses can enhance future treatments, particularly through Knowledge-Based Planning, and aid in developing new treatment modalities like convergent kV RT.&#xD;Purpose: The objective is to develop automated software tools for large-scale retrospective analysis of over 10,000 MeV x-ray radiotherapy plans. This aims to identify trends and references in plans delivered at our institution across all treatment sites, focusing on: (A) Planning-Target-Volume, Clinical-Target-Volume, Gross-Tumor-Volume, and Organ-At-Risk (PTV/CTV/GTV/OAR) topology, morphology, and dosimetry, and (B) RT plan efficiency and complexity.&#xD;Methods:&#xD;The software tools are coded in Python. Topological metrics are evaluated using principal component analysis, including center of mass, volume, size, and depth. Morphology is quantified using Hounsfield Units, while dose distribution is characterized by conformity and homogeneity indexes. The total dose within the target versus the body is defined as the Dose Balance Index. &#xD;Results:&#xD;The primary outcome of this study is the toolkit and an analysis of our database. For example, the mean minimum and maximum PTV depths are about 2.5±2.3 cm and 9±3 cm, respectively.&#xD;Conclusions:&#xD;This study provides a statistical basis for RT plans and the necessary tools to generate them. It aids in selecting plans for knowledge-based models and deep-learning networks. The site-specific volume and depth results help identify the limitations and opportunities of current and future treatment modalities, in our case convergent kV RT. The compiled statistics and tools are versatile for training, quality assurance, comparing plans from different periods or institutions, and establishing guidelines. The toolkit is publicly available at https://github.com/m-kinz/STAR.

Cerebral infarction remains a leading cause of mortality and long-term disability globally, underscoring the critical importance of early diagnosis and timely intervention to enhance patient outcomes. This study introduces a novel approach to cerebral infarction segmentation using a novel dataset comprising MRI scans of 110 patients, retrospectively collected from Yozgat Bozok University Research Hospital. Two convolutional neural network architectures, the basic U-Net and the advanced U-Net3 + , are employed to segment infarction regions with high precision. Ground-truth annotations are generated under the supervision of an experienced radiologist, and data augmentation techniques are applied to address dataset limitations, resulting in 6732 balanced images for training, validation, and testing. Performance evaluation is conducted using metrics such as the dice score, Intersection over Union (IoU), pixel accuracy, and specificity. The basic U-Net achieved superior performance with a dice score of 0.8947, a mean IoU of 0.8798, a pixel accuracy of 0.9963, and a specificity of 0.9984, outperforming U-Net3 + despite its simpler architecture. U-Net3 + , with its complex structure and advanced features, delivered competitive results, highlighting the potential trade-off between model complexity and performance in medical imaging tasks. This study underscores the significance of leveraging deep learning for precise and efficient segmentation of cerebral infarction. The results demonstrate the capability of CNN-based architectures to support medical decision-making, offering a promising pathway for advancing stroke diagnosis and treatment planning.

This study aims to evaluate the success of artificial intelligence models developed using convolutional neural network-based algorithms on CBCT images. Labeling was done by segmentation method for 15 different conditions including caries, restorative filling material, root-canal filling material, dental implant, implant supported crown, crown, pontic, impacted tooth, supernumerary tooth, residual root, osteosclerotic area, periapical lesion, radiolucent jaw lesion, radiopaque jaw lesion, and mixed appearing jaw lesion on the data set consisting of 300 CBCT images. In model development, the Mask R-CNN architecture and ResNet 101 model were used as a transfer learning method. The success metrics of the model were calculated with the confusion matrix method. When the F1 scores of the developed models were evaluated, the most successful dental implant was found to be 1, and the lowest F1 score was found to be a mixed appearing jaw lesion. F1 scores were respectively dental implant, root canal filling material, implant supported crown, restorative filling material, radiopaque jaw lesion, crown, pontic, impacted tooth, caries, residual tooth root, radiolucent jaw lesion, osteosclerotic area, periapical lesion, supernumerary tooth, for mixed appearing jaw lesion; 1 is 0.99, 0.98, 0.98, 0.97, 0.96, 0.96, 0.95, 0.94, 0.94, 0.94, 0.90, 0.90, 0.87, and 0.8. Interpreting CBCT images is a time-consuming process and requires expertise. In the era of digital transformation, artificial intelligence-based systems that can automatically evaluate images and convert them into report format as a decision support mechanism will contribute to reducing the workload of physicians, thus increasing the time allocated to the interpretation of pathologies.

Accurate tumor delineation is foundational to radiotherapy. In the era of deep learning, the automation of this labor-intensive and variation-prone process is increasingly tractable. We developed a deep neural network model to segment gross tumor volumes (GTVs) in the lung and propagate them across 4D CT images to generate an internal target volume (ITV), capturing tumor motion during respiration. Using a multicenter cohort-based registry from 9 clinics across 2 health systems, we trained a 3D UNet model (iSeg) on pre-treatment CT images and corresponding GTV masks (n = 739, 5-fold cross-validation) and validated it on two independent cohorts (n = 161; n = 102). The internal cohort achieved a median Dice (DSC) of 0.73 [IQR: 0.62-0.80], with comparable performance in external cohorts (DSC = 0.70 [0.52-0.78] and 0.71 [0.59-79]), indicating multi-site validation. iSeg matched human inter-observer variability and was robust to image quality and tumor motion (DSC = 0.77 [0.68-0.86]). Machine-generated ITVs were significantly smaller than physician delineated contours (p < 0.0001), indicating more precise delineation. Notably, higher false positive voxel rate (regions segmented by the machine but not the human) were associated with increased local failure (HR: 1.01 per voxel, p = 0.03), suggesting the clinical relevance of these discordant regions. These results mark a leap in automated target volume segmentation and suggest that machine delineation can enhance the accuracy, reproducibility, and efficiency of this core task in radiotherapy.

The application of artificial intelligence (AI) in medicine has garnered significant attention in recent years, offering new possibilities for improving patient care across various domains. For herpes zoster, a viral infection caused by the reactivation of the varicella-zoster virus, AI technologies have shown remarkable potential in enhancing disease diagnosis, treatment, and management. This study aims to investigate the current research status in the use of AI for herpes zoster, offering a comprehensive synthesis of existing advancements. A systematic literature review was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Three databases of Web of Science Core Collection, PubMed, and IEEE were searched to identify relevant studies on AI applications in herpes zoster research on November 17, 2023. Inclusion criteria were as follows: (1) research articles, (2) published in English, (3) involving actual AI applications, and (4) focusing on herpes zoster. Exclusion criteria comprised nonresearch articles, non-English papers, and studies only mentioning AI without application. Two independent clinicians screened the studies, with a third senior clinician resolving disagreements. In total, 26 articles were included. Data were extracted on AI task types; algorithms; data sources; data types; and clinical applications in diagnosis, treatment, and management. Trend analysis revealed an increasing annual interest in AI applications for herpes zoster. Hospital-derived data were the primary source (15/26, 57.7%), followed by public databases (6/26, 23.1%) and internet data (5/26, 19.2%). Medical images (9/26, 34.6%) and electronic medical records (7/26, 26.9%) were the most commonly used data types. Classification tasks (85.2%) dominated AI applications, with neural networks, particularly multilayer perceptron and convolutional neural networks being the most frequently used algorithms. AI applications were analyzed across three domains: (1) diagnosis, where mobile deep neural networks, convolutional neural network ensemble models, and mixed-scale attention-based models have improved diagnostic accuracy and efficiency; (2) treatment, where machine learning models, such as deep autoencoders combined with functional magnetic resonance imaging, electroencephalography, and clinical data, have enhanced treatment outcome predictions; and (3) management, where AI has facilitated case identification, epidemiological research, health care burden assessment, and risk factor exploration for postherpetic neuralgia and other complications. Overall, this study provides a comprehensive overview of AI applications in herpes zoster from clinical, data, and algorithmic perspectives, offering valuable insights for future research in this rapidly evolving field. AI has significantly advanced herpes zoster research by enhancing diagnostic accuracy, predicting treatment outcomes, and optimizing disease management. However, several limitations exist, including potential omissions from excluding databases like Embase and Scopus, language bias due to the inclusion of only English publications, and the risk of subjective bias in study selection. Broader studies and continuous updates are needed to fully capture the scope of AI applications in herpes zoster in the future.